loadpatents
Patent applications and USPTO patent grants for Ley; Arthur C..The latest application filed is for "prevention and reduction of blood loss".
Patent | Date |
---|---|
Prevention and reduction of blood loss Grant 9,480,733 - Ladner , et al. November 1, 2 | 2016-11-01 |
Kallikrein-inhibitor therapies Grant 9,114,144 - Ladner , et al. August 25, 2 | 2015-08-25 |
Prevention And Reduction Of Blood Loss App 20140349940 - Ladner; Robert C. ;   et al. | 2014-11-27 |
Prevention and reduction of blood loss Grant 8,710,007 - Ladner , et al. April 29, 2 | 2014-04-29 |
Poly-pegylated Protease Inhibitors App 20120322744 - Ley; Arthur C. ;   et al. | 2012-12-20 |
Prevention and reduction of blood loss Grant 8,124,586 - Ladner , et al. February 28, 2 | 2012-02-28 |
Kallikrein-inhibitor Therapies App 20120015881 - Ladner; Robert C. ;   et al. | 2012-01-19 |
Kallikrein-inhibitor therapies Grant 8,034,775 - Ladner , et al. October 11, 2 | 2011-10-11 |
Poly-Pegylated Protease Inhibitors App 20110172140 - Ley; Arthur C. ;   et al. | 2011-07-14 |
Albumin-Fused Kunitz Domain Peptides App 20110092413 - Hauser; Hans-Peter ;   et al. | 2011-04-21 |
Prevention And Reduction Of Blood Loss App 20110086801 - Ladner; Robert C. ;   et al. | 2011-04-14 |
Prevention and reduction of blood loss Grant 7,851,442 - Ladner , et al. December 14, 2 | 2010-12-14 |
Plasmin-inhibitory Therapies App 20100286061 - DEVY; Laetitia ;   et al. | 2010-11-11 |
Prevention and reduction of blood loss Grant 7,811,991 - Ladner , et al. October 12, 2 | 2010-10-12 |
Kallikrein-inhibitor therapies Grant 7,704,949 - Ladner , et al. April 27, 2 | 2010-04-27 |
Kallikrein-inhibitor Therapies App 20100034805 - Ladner; Robert C. ;   et al. | 2010-02-11 |
Poly-pegylated protease inhibitors Grant 7,550,427 - Ley , et al. June 23, 2 | 2009-06-23 |
Systems And Methods For Purifying Proteins App 20090149638 - Ley; Arthur C. ;   et al. | 2009-06-11 |
Kallikrein-inhibitor Therapies App 20090117130 - Ladner; Robert C. ;   et al. | 2009-05-07 |
Prevention and Reduction of Blood Loss App 20090082267 - Ladner; Robert C. ;   et al. | 2009-03-26 |
Kallikrein-Inhibitor Therapies App 20090062195 - Ladner; Robert C. ;   et al. | 2009-03-05 |
Albumin-Fused Kunitz Domain Peptides App 20080274969 - Hauser; Hans-Peter ;   et al. | 2008-11-06 |
Prevention And Reduction Of Blood Loss App 20080260752 - Ladner; Robert C. ;   et al. | 2008-10-23 |
Kallikrein-Inhibitor Therapies App 20080226655 - Ladner; Robert C. ;   et al. | 2008-09-18 |
Prevention And Reduction Of Blood Loss App 20080200646 - Ladner; Robert C. ;   et al. | 2008-08-21 |
Prevention And Reduction Of Blood Loss App 20080152656 - Ladner; Robert C. ;   et al. | 2008-06-26 |
Kallikrein-Inhibitor Therapies App 20080139473 - Ladner; Robert C. ;   et al. | 2008-06-12 |
Prevention and Reduction of Blood Loss App 20080131426 - Ladner; Robert C. ;   et al. | 2008-06-05 |
Prevention And Reduction Of Blood Loss App 20080076712 - Ladner; Robert C. ;   et al. | 2008-03-27 |
Prevention and reduction of blood loss App 20080064637 - Ladner; Robert C. ;   et al. | 2008-03-13 |
Prevention And Reduction Of Blood Loss App 20070249807 - Ladner; Robert C. ;   et al. | 2007-10-25 |
Prevention and reduction of blood loss Grant 7,276,480 - Ladner , et al. October 2, 2 | 2007-10-02 |
Serum albumin binding moieties Grant 7,211,395 - Sato , et al. May 1, 2 | 2007-05-01 |
Kallikrein-inhibitor Therapies App 20070049522 - Ladner; Robert C. ;   et al. | 2007-03-01 |
Poly-pegylated Protease Inhibitors App 20070041959 - Ley; Arthur C. ;   et al. | 2007-02-22 |
Novel enterokinase cleavage sequences App 20070031879 - Ley; Arthur C. ;   et al. | 2007-02-08 |
Modified protease inhibitors App 20070020252 - Ladner; Robert C. ;   et al. | 2007-01-25 |
Kallikrein-inhibitor therapies Grant 7,153,829 - Ladner , et al. December 26, 2 | 2006-12-26 |
Prevention and reduction of blood loss App 20060194727 - Ladner; Robert C. ;   et al. | 2006-08-31 |
ITI-D1 Kunitz domain mutants as HNE inhibitors Grant 7,078,383 - Ley , et al. July 18, 2 | 2006-07-18 |
Prevention and reduction of blood loss Grant 7,064,107 - Ladner , et al. June 20, 2 | 2006-06-20 |
Plasmin-inhibitory therapies App 20060111296 - Devy; Laetitia ;   et al. | 2006-05-25 |
Kunitz domain peptides Grant 6,989,369 - Ladner , et al. January 24, 2 | 2006-01-24 |
Albumin-fused kunitz domain peptides App 20050222023 - Hauser, Hans-Peter ;   et al. | 2005-10-06 |
Kallikrein-inhibitor therapies App 20050164928 - Ladner, Robert C. ;   et al. | 2005-07-28 |
Novel enterokinase cleavage sequences App 20050158838 - Ley, Arthur C. ;   et al. | 2005-07-21 |
Poly-pegylated protease inhibitors App 20050089515 - Ley, Arthur C. ;   et al. | 2005-04-28 |
Kunitz domain peptides App 20040171794 - Ladner, Robert Charles ;   et al. | 2004-09-02 |
Prevention and reduction of blood loss App 20040038893 - Ladner, Robert C. ;   et al. | 2004-02-26 |
Binding molecules for Fc-region polypeptides App 20030199671 - Rondon, Isaac Jesus ;   et al. | 2003-10-23 |
Serum albumin binding moieties App 20030069395 - Sato, Aaron K. ;   et al. | 2003-04-10 |
Directed evolution of novel binding proteins Grant 5,571,698 - Ladner , et al. * November 5, 1 | 1996-11-05 |
Viruses expressing chimeric binding proteins Grant 5,403,484 - Ladner , et al. April 4, 1 | 1995-04-04 |
Directed evolution of novel binding proteins Grant 5,223,409 - Ladner , et al. | 1993-06-29 |
Generation and selection of novel DNA-binding proteins and polypeptides Grant 5,198,346 - Ladner , et al. March 30, 1 | 1993-03-30 |
Generation and selection of novel DNA-binding proteins and polypeptides Grant 5,096,815 - Ladner , et al. March 17, 1 | 1992-03-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.